Patent ID: 11958910
Assignee: REGENERON PHARMACEUTICALS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 20:
21. The bispecific antigen-binding molecule of claim 20, wherein D1 comprises an HCDR1 amino acid sequence as set forth in SEQ ID NO: 4; an HCDR2 amino acid sequence as set forth in SEQ ID NO: 6; an HCDR3 amino acid sequence as set forth in SEQ ID NO: 8; an LCDR1 amino acid sequence as set forth in SEQ ID NO: 20; an LCDR2 amino acid sequence as set forth in SEQ ID NO: 22; and an LCDR3 amino acid sequence as set forth in SEQ ID NO: 24.